Dexamethasone and N-acetyl-cysteine attenuate Pseudomonas aeruginosa-induced mucus expression in human airways

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2011, Pages 232-239

  Sprenger, Lisa ^a   Goldmann, Torsten ^a   Vollmer, Ekkehard ^a   Steffen, Armin ^b   Wollenberg, Barbara ^b   Zabel, Peter ^a   Hauber, Hans Peter ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Airway; Dexamethasone; Lipopolysaccharide; Mucosa; Mucus; N acetyl cysteine; Pseudomonas aeruginosa

Indexed keywords

ACETYLCYSTEINE; ALGINIC ACID; DEXAMETHASONE; LIPOPOLYSACCHARIDE; MUCIN 5AC;

AIRWAY DYNAMICS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; MUCUS SECRETION; NUCLEOTIDE SEQUENCE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT MUCOSA;

ACETYLCYSTEINE; ANTI-INFLAMMATORY AGENTS; CELL LINE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; EXPECTORANTS; GENE EXPRESSION REGULATION; HUMANS; MUCIN 5AC; MUCUS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY MUCOSA;

EID: 79951958437     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.11.003     Document Type: Article

References (34)

1. Bryan C.S., Reynolds K.L. Bacteremic nosocomial pneumonia: analysis of 172 single episodes from one metropolitan area. Am Rev Respir Dis 1984, 129:668-671.
2. Bodey G.P., Bolivar R., Fainstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1993, 5:270-313.
3. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 2003, 168:918-951.
4. Ratjen F., Doring G. Cystic fibrosis. Lancet 2003, 361:681-689.
5. Lieberman D., Lieberman D. Pseudomonal infection in patients with COPD: epidemiology and management. Am J Respir Med 2003, 2:459-468.
6. Murphy T.F. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease. Curr Opin Pulm Med 2009, 15:138-142.
7. Staugas R.E., Harvey D.P., Ferrante A., Nandoskar M., Allison A.C. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and eotaxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Infect Immun 1992, 60:3162-3168.
8. Koyama S., Sato E., Nomure H., Kubo K., Miura M., Yamashita T., et al. The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol 2000, 278:L658-L666.
9. Baggiolini M., Walz A., Kunkel S.L. Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989, 84:1045-1049.
10. Leonard E.J., Yoshimura T. Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Crit Care Med 1990, 2:479-486.
11. Klinger J.D., Tandler B., Liedtke C.M., Boat T.F. Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium. J Clin Invest 1984, 74:1669-1678.
12. Voynow J.A., Young L.R., Wang Y., Horger T., Rose M.C., Fischer B.M. Neutrophil elastase induces MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 1999, 276:L835-L843.
13. Dohrman A., Miyata S., Gallup M., Li J.D., Chapelin C., Coste E., et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1998, 1406:251-259.
14. Li J.D., Feng W., Gallup M., Kim J.H., Gum J., Kim Y., et al. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 1998, 95:5718-5723.
15. Barnes P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998, 94:557-572.
16. Tunek A. Possible mechanisms behind the anti-inflammatory effects of N-acetylcysteine: is metabolism essential?. Eur Respir Rev 1992, 2:35-38.
17. Repine J.E., Bast A., Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 156:341-357.
18. Chen Y., Nickola T.J., DiFronzo N.L., Colberg-Poley A.M., Rose M.C. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2005, 34:338-347.
19. Kai H., Yoshitake K., Hisatsune A., Kido T., Isohama Y., Takahama K., et al. Dexamethasone suppresses mucus production and MUC2 and MUC5AC gene expression by NCI-H292 cells. Am J Physiol 1996, 271:L484-L488.
20. Marom Z., Shelhamer J., Alling D., Kaliner N. The effects of corticosteroids on mucous glycoprotein secretion from human airways in vitro. Am Rev Respir Dis 1984, 129:62-65.
21. Hauber H.P., Goldmann T., Vollmer E., Wollenberg B., Zabel P. Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa. Am J Respir Cell Mol Biol 2007, 35:606-616.
22. Dandurand R.J., Wang C.G., Laberge S., Martin J.G., Eidelman D.H. In vitro allergic bronchoconstriction in the Brown Norway rat. Am J Respir Crit Care Med 1994, 149:1499-1505.
23. Minshall E., Wang C.G., Dandurand R., Eidelman D. Heterogeneity of responsiveness of individual airways in cultured lung explants. Can J Physiol Pharmacol 1997, 75:911-916.
24. Goldmann T., Vollmer E., Gerdes J. What's Cooking? Detection of important biomarkers in HOPE-fixed, paraffin-embedded tissues eliminates the need for antigen retrieval. Am J Pathol 2003, 163:2638-2640.
25. Lu W., Lillehoj E., Kim K.C. Effects of dexamethasone on MUC5AC mucin production by primary airway goblet cells. Am J Physiol Lung Cell Mol Physiol 2005, 288:L52-L60.
26. Redondo P., Jiminez E., Perez A., Garcia-Foncillas J. N-acetylcysteine downregulates vascular endothelial growth factor production by human keratinocytes in vitro. Arch Dermatol Res 2000, 292:621-628.
27. Hovenberg H.W., Davies J.R., Herrmann A., Linden C.J., Carlstedt I. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 1996, 13:839-847.
28. Høiby N., Krogh Johansen H., Moser C., Song Z., Ciofu O., Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001, 3:23-35.
29. Lam J., Chan R., Lam K., Costerton J.W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980, 28:546-556.
30. Lyczak J.B., Cannon C.L., Pier G.B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002, 15:194-222.
31. Fischer B.M., Voynow J.A. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 2002, 26:447-452.
32. Shao M.X., Nadel J.A. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 2005, 102:767-772.
33. Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005, 365:1552-1560.
34. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., et al. IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005, 353:2229-2242.